Wednesday, 22 June 2011
08:30-10:00 | Plenary session: Targeted therapy in melanoma: present and future
Chairs: Roland Kauffman (Germany), Helen Gogas (Greece), Philippe Saiag (France)
- Monoclonal antibodies in melanoma
John Kirkwood (United States) - Antigen specific immunotherapy
Brigitte Dréno (France) - Targeted therapy
Peter Hersey (Australia) - Anti angiogenic factors
Christoph Höller (Austria) - Cutaneous side effects and new drugs: how to manage?
Caroline Robert (France)
- Take home messages Claus Garbe (Germany)
10:00-10:30 | Coffee break
10:30-11:00 | Guest Lecture
Chairs: Giovanni Pellacini (Italy), Judith Olah (Hungary)
- Genetic bases of human pigmentation: hope for new treatments?
Richard A. Sturm (Australia)
11:00-12:30 | Plenary session: Melanoma: from basic research to practice
Chairs: Céleste Lebbé (France), Pierre Coulie (Belgium), Dirk Schadendorf (Germany)
- Towards optimal selection of antigen specific T cells for adoptive therapy of melanoma
Nathalie Labarrière (France) - Cells cultures and animal models in melanoma: new perspectives
Jürgen Becker (Germany) - Human T cells responses against melanoma
Pierre Coulie (Belgium) - Melanoma Genetic
Julia Newton-Bishop (United Kingdom) - Melanoma stem cell: still more questions than answers
Lionel Larue (France)
- Take home messages Céleste Lebbé (France)
12:30-14:00 | Lunch - Sponsored by Bristol-Myers Squibb - Posters session
13:00-14:00 | Satellite symposium Galderma:
Tailoring Photodynamic Therapy to improve patient outcomes
Chair: Brigitte Dréno (France)
- Actinic keratosis: Rationale for the concept of field cancerization
Rianne Gerritsen (The Netherlands) - Can topical treatments and photodynamic therapy prevent squamous cell carcinoma in patients
with actinic keratosis?
Claas Ulrich (Germany) - Photodynamic therapy: how to achieve efficacy without pain
Alexis Sidoroff (Austria)
14:00-15:30 | Free oral communications
Chairs: Georg Weinlich (Austria), Eggert Stockfleth (Germany), Marie-Thérèse Leccia (France)
CO19 | Is primary melanoma ulceration a factor of good response to adoptive immunotherapy?
Peuvrel L, Nguyen JM, Khammari A, Quéreux G, Brocard A, Dréno B (France)
CO20 | Percutaneous hepatic perfusion (PHP) for metastatic melanoma: Results from a single institution
Zager JS (USA)
CO21 | HFS-14, a specific quality of life scale developed for patients suffering from hand-foot syndrome
Sibaud V, Dalenc F, Chevreau C, Roché H, Delord JP, Mourey L, Lacaze JL, Rahhali N, Taieb C (France)
CO22 | Long term outcomes after interstitial brachytherapy for lower lip carcinoma: a retrospective study of 95 cases
Mervoyer A, Rio E, Bardet E, Malard O, Piot B, Dréno B (France)
CO23 | The determinants of periorbital skin aging in a North European population
Suppa M, Elliott F, Mikeljevic JS, Mukasa Y, Chan M, Leake S, Karpavicius B, Haynes S, Bakker B, Peris K, Barrett JH, Bishop DT, Newton Bishop JA (United Kingdom, Italy, The Netherlands)
CO24 | Seasonal variations in vitamin D levels in melanoma patients: a single-center prospective pilot comparative study
El Hayderi L, Failla V, Cavalier E, Paurobally D, Chapelle JP, Dezfoulian B, Nikkels AF (Belgium)
CO25 | Suberoylanilide hydroxamic acid (Vorinostat) plus Mithramycin A (Plicamycin) treatments in Sézary lymphoma
Bonnet N, Berbis P, Kahn-Perlès B, Costello R (France)
CO26 | Results of a phase 1/2 study for KW-0761, a monoclonal antibody directed against CC chemokine receptor type 4 (CCR4), in CTCL patients
Kim YH, Pinter-Brown L, Foss F, Sokol L, Jorgensen JL, Spitalny GL, Duvic M (USA)
CO27 | Interest of Cetuximab in the treatment of cutaneous squamous cell carcinoma
Preneau S, Quéreux G, Brocard A, Peuvrel L, Dréno B (France)
15:30-16:00 | Coffee break by Leo Pharma
16:00-17:30 | Plenary session: Melanoma: imaging technique for our pratice in 2011
Chairs: Colin Morton (United Kingdom), Ketty Peris (Italy), Laurent Mortier (France)
- Confocal Microscopy
Giovanni Pellacini (Italy) - Dermoscopy
Luc Thomas (France) - Ultrasound
Alessandro Testori (Italy) - Telemedicine
Alexander Stratigos (Greece) - From imaging to molecular biology
Josep Malvehy (Spain)
- Take home messages Jürgen Becker (Germany)